BeiGene
BGNE
#926
Rank
$21.32 B
Marketcap
$190.51
Share price
-2.08%
Change (1 day)
3.14%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

We have found no dividend yield history for this company